Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass

Th17 Cells Undergo Fas-Mediated Activation-Induced Cell Death Independent of IFN- 

(2014) Y. Zhang et al.   JOURNAL OF IMMUNOLOGY

CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance

(2013) Adam Greenbaum et al.   NATURE

IFN-γ and TNF-α Synergistically Induce Mesenchymal Stem Cell Impairment and Tumorigenesis via NFκB Signaling

(2013) Lei Wang et al.   STEM CELLS

The HIF Signaling Pathway in Osteoblasts Directly Modulates Erythropoiesis through the Production of EPO

(2012) Erinn B. Rankin et al.   CELL

Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis

(2012) Kentaro Akiyama et al.   Cell Stem Cell

ERα signaling regulates MMP3 expression to induce FasL cleavage and osteoclast apoptosis

(2012) Alejandro J Garcia et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteoprotection by semaphorin 3A

(2012) Mikihito Hayashi et al.   NATURE

Osteoporosis: now and the future

(2011) Tilman D Rachner et al.   LANCET

Mesenchymal stem cell–based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α

(2011) Yi Liu et al.   NATURE MEDICINE

Matrix-embedded cells control osteoclast formation

(2011) Jinhu Xiong et al.   NATURE MEDICINE

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

(2011) Tomoki Nakashima et al.   NATURE MEDICINE

Suppression of bone formation by osteoclastic expression of semaphorin 4D

(2011) Takako Negishi-Koga et al.   NATURE MEDICINE

New targets for intervention in the treatment of postmenopausal osteoporosis

(2011) E. Michael Lewiecki   Nature Reviews Rheumatology

Inhibition of Sca-1-Positive Skeletal Stem Cell Recruitment by Alendronate Blunts the Anabolic Effects of Parathyroid Hormone on Bone Remodeling

(2010) Xiangwei Wu et al.   Cell Stem Cell

Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

(2010) A. Michael Parfitt et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice

(2010) Takashi Kikuiri et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Mouse Mandible Contains Distinctive Mesenchymal Stem Cells

(2010) T. Yamaza et al.   JOURNAL OF DENTAL RESEARCH

Fas receptor is required for estrogen deficiency-induced bone loss in mice

(2010) Natasa Kovacic et al.   LABORATORY INVESTIGATION

Bisphosphonates for Osteoporosis

(2010) Murray J. Favus   NEW ENGLAND JOURNAL OF MEDICINE

Osteoimmunology: Crosstalk Between the Immune and Bone Systems

(2009) Tomoki Nakashima et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Estrogen-dependent and C-C chemokine receptor-2–dependent pathways determine osteoclast behavior in osteoporosis

(2009) Nikolaus B Binder et al.   NATURE MEDICINE

TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation

(2009) Yi Tang et al.   NATURE MEDICINE

Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival

(2008) Susan A Krum et al.   EMBO JOURNAL

Prevention of Autoimmunity and Control of Recall Response to Exogenous Antigen by Fas Death Receptor Ligand Expression on T Cells

(2008) Imed Mabrouk et al.   IMMUNITY

Pharmacologic Stem Cell Based Intervention as a New Approach to Osteoporosis Treatment in Rodents

(2008) Takayoshi Yamaza et al.   PLoS One